πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7794998

Primate T-lymphotropic viruses

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7795208

Methods of using deacetylase inhibitors to promote cell differentiation and regeneration

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7794714

Newcastle disease virus monoclonal antibodies

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7790186

Plasmodium vivax hybrid circumsporozoite protein and vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7790764

Biologically active macrolides, compositions, and uses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7790735

Methanocarba cycloalkyl nucleoside analogues

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7790181

Live attenuated viral vaccines for Eastern Equine Encephalitis virus

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7790473

Biofunctionalized quantum dots for biological imaging

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7790182

Protein vaccines against poxviruses

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7785565

Metal chelators and methods of their use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7786285

Recombinant vaccine against botulinum neurotoxin

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7781445

Synthesis of indenoisoquinoliniums and methods of use

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7780966

Artificial invaplex

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7777019

Mutated Anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7776883

Quinolin-4-ones as inhibitors of retroviral integrase for the treatment of HIV, AIDS and A

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7776607

Mammalian selenoprotein differentially expressed in tumor cells

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7776521

Coronavirus isolated from humans

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7776337

Bacteriocins and novel bacterial strains

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7771715

Recombinant vector expressing multiple costimulatory molecules and uses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7771956

Method for detecting the presence of a phospholipid

The United States of Americaβ€”Department of Veterans Affairs Β· Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7771729

Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant adm

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7767645

SH2 domain binding inhibitors

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 03 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7763451

Methods for preparing Bacillus anthracis protective antigen for use in vaccines

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jul 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7763719

Variants of humanized anti-carcinoma MAb CC49

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jul 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted